N1-Methyl-lysergic acid diethylamide
N1-Methyl-lysergic acid diethylamide[edit | edit source]
N1-Methyl-lysergic acid diethylamide (MLD-41) is a chemical compound that belongs to the ergoline family. It is a derivative of lysergic acid diethylamide (LSD), which is a well-known psychedelic drug. MLD-41 is characterized by the addition of a methyl group at the N1 position of the lysergic acid moiety.
Chemical Structure[edit | edit source]
MLD-41 shares a similar core structure with LSD, which is based on the ergoline skeleton. The primary difference between MLD-41 and LSD is the presence of a methyl group attached to the nitrogen atom at the N1 position. This modification can influence the compound's pharmacological properties and its interaction with serotonin receptors.
Pharmacology[edit | edit source]
MLD-41, like other ergoline derivatives, is believed to interact with various neurotransmitter systems in the brain, particularly the serotonin system. The addition of the methyl group may alter its binding affinity and efficacy at serotonin receptors, potentially leading to differences in its psychoactive effects compared to LSD.
Effects[edit | edit source]
The psychoactive effects of MLD-41 are not as well-documented as those of LSD. However, it is hypothesized that MLD-41 may produce similar hallucinogenic effects, including alterations in perception, mood, and cognition. The specific effects and potency of MLD-41 relative to LSD remain a subject of research.
Synthesis[edit | edit source]
The synthesis of MLD-41 involves the chemical modification of LSD. This process typically requires the introduction of a methyl group to the N1 position of the lysergic acid diethylamide molecule. The synthesis of such compounds is complex and requires expertise in organic chemistry.
Legal Status[edit | edit source]
The legal status of MLD-41 varies by country. In many jurisdictions, it may be classified under the same legal framework as LSD due to its structural similarity and potential for psychoactive effects. Researchers and chemists must be aware of the legal implications of working with such compounds.
Related Compounds[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
